Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiran He

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal for Immunotherapy of Cancer|February 26, 2022
Peptidic microarchitecture-trapped tumor vaccine combined with immune checkpoint inhibitor or PI3Kγ inhibitor can enhance immunogenicity and eradicate tumorsYang Du, Ye Liu, Di Wang, et al.
Scientific Reports|February 19, 2021
Evaluation of the ex vivo liver viability using a nuclear magnetic resonance relaxation time-based assay in a porcine machine perfusion modelQing OuYang, Guohai Liang, Xiaoyu Tan, et al.
Translational Oncology|June 30, 2021
TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinibRuofei Yu, Hua Bai, Tangai Li, et al.
Free Radical Biology & Medicine|September 21, 2025
ICAT drives lactylation of tumor-associated macrophages via the c-Myc-ENO1 axis to promote cervical cancer progressionTingting Dang, Yiqing You, Lan Wei, et al.
Cellular Signalling|June 8, 2026
BMP9 promotes osteogenic differentiation of BMSCs via the lncRNA SNHG3/miR-619-5p axis in a breast cancer bone metastatic microenvironmentMengxin Sun, Shiyan Liu, Qian Li, et al.
Journal of Visualized Experiments : Jove|July 1, 2024
Preservation of Porcine Donation after Circulatory Death (DCD) Liver by Perfusion and Orthotopic Liver TransplantationQing OuYang, Xiaoyu Tan, Liyue Sun, et al.
Journal for Immunotherapy of Cancer|October 29, 2020
Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinomaXiran He, Yang Du, Zhijie Wang, et al.
BMC Medicine|November 10, 2022
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumorsPei Zhang, Yang Du, Hua Bai, et al.
Scientific Reports|November 6, 2025
Efferocytosis-related signatures identified via Single-cell analysis and machine learning predict TNBC outcomes and immunotherapy responseLan Wei, Siyang Wen, Tingting Dang, et al.
Cancer Letters|December 8, 2025
BMP9 potentiates immunotherapy in triple-negative breast cancer by suppressing Tregs infiltration via the PRKDC-CCL2 axisYiqing You, Lan Wei, Meng Dai, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|February 26, 2022
Peptidic microarchitecture-trapped tumor vaccine combined with immune checkpoint inhibitor or PI3Kγ inhibitor can enhance immunogenicity and eradicate tumorsYang Du, Ye Liu, Di Wang, et al.
Scientific Reports|February 19, 2021
Evaluation of the ex vivo liver viability using a nuclear magnetic resonance relaxation time-based assay in a porcine machine perfusion modelQing OuYang, Guohai Liang, Xiaoyu Tan, et al.
Translational Oncology|June 30, 2021
TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinibRuofei Yu, Hua Bai, Tangai Li, et al.
Free Radical Biology & Medicine|September 21, 2025
ICAT drives lactylation of tumor-associated macrophages via the c-Myc-ENO1 axis to promote cervical cancer progressionTingting Dang, Yiqing You, Lan Wei, et al.
Cellular Signalling|June 8, 2026
BMP9 promotes osteogenic differentiation of BMSCs via the lncRNA SNHG3/miR-619-5p axis in a breast cancer bone metastatic microenvironmentMengxin Sun, Shiyan Liu, Qian Li, et al.
Journal of Visualized Experiments : Jove|July 1, 2024
Preservation of Porcine Donation after Circulatory Death (DCD) Liver by Perfusion and Orthotopic Liver TransplantationQing OuYang, Xiaoyu Tan, Liyue Sun, et al.
Journal for Immunotherapy of Cancer|October 29, 2020
Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinomaXiran He, Yang Du, Zhijie Wang, et al.
BMC Medicine|November 10, 2022
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumorsPei Zhang, Yang Du, Hua Bai, et al.
Scientific Reports|November 6, 2025
Efferocytosis-related signatures identified via Single-cell analysis and machine learning predict TNBC outcomes and immunotherapy responseLan Wei, Siyang Wen, Tingting Dang, et al.
Cancer Letters|December 8, 2025
BMP9 potentiates immunotherapy in triple-negative breast cancer by suppressing Tregs infiltration via the PRKDC-CCL2 axisYiqing You, Lan Wei, Meng Dai, et al.
Pageof 3